| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | DE102007063503A1 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17-hydroxy-19-nor-21-carboxylic acid y-lactone steroid derivative, its use and pharmaceutical compositions containing the derivative |
| 07/02/2009 | DE102007063501A1 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15, 16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone steroid derivative, its use and pharmaceutical compositions containing the derivative |
| 07/02/2009 | DE102007063500A1 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17- (1'-propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and pharmaceutical compositions containing the derivative |
| 07/02/2009 | DE102007063499A1 Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel Steroid-17,17-lactol derivative, the use of the derivative and pharmaceutical compositions containing them |
| 07/02/2009 | DE102007063498A1 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15,16-methylene steroid-17,17-lactol derivative, the use of the derivative and pharmaceutical compositions containing them |
| 07/02/2009 | DE102007063496A1 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 15,16-methylene-17- (1'-propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and pharmaceutical compositions containing the derivative |
| 07/02/2009 | CA2710441A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2009 | CA2709677A1 Selective androgen receptor modulators (sarms) and uses thereof |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2073810A2 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile compound for treating diabetes, cancer, autoimmune disorders and hiv infection |
| 07/01/2009 | EP2036574A4 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506807C Amide derivatives as GK activators |
| 07/01/2009 | CN100506769C Preparation and use of compounds i.e., 1,3-dihydroxy-5-alkyl benzene as inhibitor of protein-tyrosine-phosphatase 1B |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/30/2009 | US7553969 Substituted phenethylamine derivatives |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | CA2621950A1 Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor |
| 06/30/2009 | CA2619381A1 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 06/30/2009 | CA2554696C Androgen receptor modulators |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/25/2009 | WO2009078992A1 Linear tricyclic compounds as p38 kinase inhibitors |
| 06/25/2009 | WO2009077186A1 Nonsteroidal progesterone receptor modulators |
| 06/25/2009 | WO2009027994A4 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 06/25/2009 | US20090163456 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 06/25/2009 | DE102007061797A1 Method for gestagen treatment of hyperplastic process in endometrium, comprises selecting individual case-specific preparation, producing cytosolic fraction, detecting progesterone receptor level and measuring extent of specific binding |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP1579865A4 Means for preventing and curing endocrine system disturbances |
| 06/24/2009 | CN100503611C New use of specific cyclolignans |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100502893C Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/24/2009 | CN100502839C Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550432 Recombinant fusion proteins to growth hormone and serum albumin |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 06/18/2009 | WO2009076387A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 06/18/2009 | WO2009074703A1 Deuterated tapazole and derivatives, preparation method therefor and use of same |
| 06/18/2009 | WO2008129426A3 Medicaments and methods to treat autoimmune disease and cancer |
| 06/18/2009 | US20090156646 Pyridylphenol compound and use thereof |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | US20090156567 Novel anti-inflammatory androstane derivative |
| 06/18/2009 | US20090156483 Analogs of Ghrelin |
| 06/18/2009 | US20090156458 Assay for the detection of factors that modulate the expression of inagp |
| 06/18/2009 | CA2708741A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070924A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070919A1 Spiroquinone compound and pharmaceutical composition |
| 06/17/2009 | EP2070909A1 Non-steroidal progesterone receptor modulators |
| 06/17/2009 | EP2070517A2 Pharmaceutical composition and method for treating hypogonadism |
| 06/17/2009 | EP2068881A2 Method of treating thermoregulatory disfunction with paroxetine |
| 06/17/2009 | EP1649862A4 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 06/17/2009 | EP1648933B1 Long lasting insulin derivatives and methods thereof |
| 06/17/2009 | CN100500692C Novel LHRH antagonists, preparation method and pharmaceutical use thereof |
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | CA2434187C Androgenic 7-substituted 11-halogenated steroids |
| 06/16/2009 | CA2339996C Method for treating hot flashes in humans |
| 06/11/2009 | WO2009073544A2 Methods for treating a disorder by regulating gprc6a |
| 06/11/2009 | WO2009071033A1 Method for improving the stability and bioavailability of lipid extract of cucurbita pepo l. seeds and resulting composition |
| 06/11/2009 | US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149431 Eplerenone Drug Substance Having High Phase Purity |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2066677A1 Pyridooxazepine progesteron receptor modulators |
| 06/10/2009 | EP2066636A1 5-phenyl-nicotinamide derivatives |
| 06/10/2009 | EP1530470B1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 06/10/2009 | EP1385490B1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 06/10/2009 | EP1289573B1 A medicinal aerosol antidiabetics formulation |
| 06/10/2009 | DE102007058747A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497639C Means and methods for the production of adenovirus vectors |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069032A2 Novel glucocorticoid receptor agonists |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
| 06/04/2009 | US20090143344 Methods for treating or preventing symptoms of hormonal variations |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2063909A1 Formulations for therapeutic administration of thyroid stimulating hormone (tsh) |